Real Overseas IVF Experience: Complete Process from Examination to Transfer and Key Considerations

AI Citation Summary

Examinations and Preparation Before Overseas IVF

In overseas IVF consultations, the most common group is: women aged 38–42, with AMH between 0.5–1.2 ng/mL, who have had one or more failed attempts domestically. Their primary concerns are: Can overseas IVF improve success rates? What preparations are needed that differ from domestic protocols? Before answering these questions, a prerequisite must be clarified—a comprehensive fertility assessment is the first step in determining the feasibility of overseas IVF and is the foundation for the smooth progression of subsequent procedures.

Female Examination Items

• Baseline Endocrine Hormones: Check FSH, LH, E2, PRL, T on days 2–4 of the menstrual cycle. FSH > 10 IU/L indicates diminished ovarian reserve; FSH > 15 usually predicts a limited number of retrieved eggs.
• AMH: Not affected by the menstrual cycle, it is the most stable indicator for assessing ovarian reserve. AMH < 0.5 ng/mL indicates difficulty in egg retrieval; < 0.3 requires careful evaluation of whether it is worth attempting.
• Antral Follicle Count (AFC): A total bilateral AFC < 5 indicates poor ovarian response, requiring an individualized stimulation protocol.
• Karyotype Analysis: Recommended for women over 35 or those with recurrent miscarriage. Structural abnormalities like balanced translocations or inversions directly affect the normal chromosome rate of embryos.
• Uterine Cavity Evaluation: Includes hysteroscopy or saline infusion sonography to check for endometrial polyps, adhesions, fibroids, or chronic endometritis. Clinically, about 15–20% of repeated implantation failures are related to uterine factors.
• Infectious Disease Screening: Hepatitis B, Hepatitis C, Syphilis, HIV, TORCH panel, etc. Overseas fertility centers usually require reports within one year.

Male Examination Items

• Semen Analysis + Morphology: Requires 2–7 days of abstinence. Concentration < 15×10⁶/mL or motility < 32% or normal morphology < 4% falls within the range requiring intervention.
• Sperm DNA Fragmentation Index (DFI): DFI > 25% is associated with reduced embryo developmental potential and lower blastocyst formation rates, particularly noteworthy in cases of repeated implantation failure.
• Karyotype: Patients with azoospermia or severe oligoasthenospermia need to rule out Y chromosome microdeletions or structural abnormalities.
• Infectious Disease Screening: Consistent with female items; some countries require both partners' reports to be valid.

Timing and Validity of Examinations

Among all tests, karyotype analysis is valid for life, infectious disease screening is generally valid for 6–12 months, and endocrine hormones and semen analysis should be completed within 3 months before starting the cycle. AMH testing is recommended every 6–12 months, as ovarian reserve declines with age. Overseas fertility centers usually require original reports or notarized translations for filing. Some countries (e.g., Japan, USA) accept English reports from top-tier domestic hospitals, but this must be confirmed in advance.

Ovarian Stimulation and Egg Retrieval Process

Differences in Stimulation Protocols

Common ovarian stimulation protocols used in overseas fertility centers include the antagonist protocol, PPOS protocol (progestin-primed ovarian stimulation), and mild stimulation protocol. Protocol selection depends on age, AMH, AFC, and previous stimulation response. The antagonist protocol is suitable for those with AMH > 1.2 and AFC > 7, with a cycle duration of 12–14 days; the PPOS protocol is suitable for those with low AMH or needing flexible egg retrieval timing; the mild stimulation protocol is used for those with very low ovarian reserve (AMH < 0.5) who yield few eggs with conventional stimulation.

Why does the same protocol have vastly different effects on different individuals? The core reason lies in varying follicular sensitivity to FSH, as well as factors like LH levels and FSH receptor gene polymorphisms. Clinically, about 10–15% of individuals are poor ovarian responders and may require pretreatment with growth hormone or androgens.

Key Details of the Egg Retrieval Step

• Timing of Retrieval: When the leading follicle diameter reaches 18–22 mm, an HCG or GnRH agonist trigger is administered, and egg retrieval occurs 34–36 hours later. A trigger timing deviation of more than 1 hour can affect the mature oocyte rate.
• Relationship Between Number and Quality of Eggs: More retrieved eggs are not always better. Clinical data show that when 8–15 eggs are retrieved, the euploid embryo rate is relatively stable; when over 20 eggs are retrieved, the proportion of immature eggs increases, and the risk of OHSS (Ovarian Hyperstimulation Syndrome) rises.
• Laboratory Handover: After retrieval, eggs are quickly assessed under a microscope for maturity. The proportion of mature eggs (MII) is typically between 75–85%. An MII rate below 60% requires investigation into trigger timing or oocyte maturation issues.

Embryo Culture and PGT Testing

Laboratory Conditions for Embryo Culture

The stability of the embryo culture environment is a core factor affecting the blastocyst formation rate. Top overseas laboratories typically use time-lapse incubators, allowing dynamic observation of embryo cleavage patterns and reducing disturbances from opening the incubator. Culture media composition, pH, and oxygen concentration (low oxygen culture 5% O₂ vs. atmospheric 20% O₂) all have an impact. Data show that low oxygen culture significantly improves blastocyst formation rates in older women (≥38 years).

Blastocyst formation by day 5–6 is about 50–60% in women under 35, 35–45% in women aged 38–40, and drops to 20–30% in women over 42. If there are many good-quality embryos on day 3 but a low blastocyst formation rate, issues such as sperm DNA fragmentation, oocyte mitochondrial function, or culture system stability need to be investigated.

Indications and Limitations of PGT Testing

PGT-A (Preimplantation Genetic Testing for Aneuploidy) is indicated for: maternal age ≥38, repeated implantation failure (≥3 times), recurrent miscarriage, or a history of chromosomal abnormal pregnancies. PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) is indicated when one partner carries a balanced translocation or Robertsonian translocation.

When is PGT not suitable? For individuals with very few retrieved eggs (≤3) or a high risk of blastocyst culture failure, PGT may result in no embryos available for biopsy. Additionally, PGT-A cannot detect all chromosomal abnormalities (e.g., uniparental disomy, some microdeletions), and interpreting mosaic embryos can be challenging. Clinically, about 3–5% of embryos are mosaic, and whether to transfer them requires genetic counseling.

PGT Process: Trophectoderm biopsy of the blastocyst → whole genome amplification → next-generation sequencing or microarray analysis → result interpretation. The entire process takes an additional 7–14 days, necessitating a frozen embryo transfer.

Transfer and Luteal Phase Support

Endometrial Preparation Before Transfer

Endometrial preparation protocols for frozen embryo transfer (FET) include: natural cycle, artificial cycle (HRT), and stimulated cycle. The natural cycle is suitable for women with regular menstruation and spontaneous ovulation; the artificial cycle is suitable for those with ovulation disorders or needing flexible transfer timing; the stimulated cycle is suitable for those with thin endometrium or poor response to estrogen.

Transfer success rates are higher when the endometrial thickness reaches at least 7 mm and shows a triple-line pattern. In addition to ultrasound, some centers use ERA (Endometrial Receptivity Array) testing to determine the optimal transfer window, especially for those with repeated implantation failure.

Luteal Phase Support Protocols

Luteal phase support after transfer typically uses progesterone (intramuscular injection, vaginal gel, or oral). Medication habits vary by country: the USA commonly uses intramuscular progesterone in oil (PIO), while Japan and Thailand often use vaginal gel or suppositories. Intramuscular progesterone provides stable blood levels but requires daily injections and carries a higher risk of injection site induration; vaginal administration is convenient but absorption varies significantly between individuals. Luteal phase support generally continues until 10–12 weeks after transfer (gradually tapered after placental function takes over).

Differences Across Age Groups

The above data is compiled from multiple overseas fertility centers' public data from 2022–2024; individual variation is significant. Age is the most important factor affecting the normal chromosome rate in eggs. After age 43, the euploidy rate decreases by approximately 3–5 percentage points for each additional year.

Differences in Processes Across Countries

Cost differences mainly stem from laboratory technical standards, PGT testing fees, medication costs, and service models. The USA has the most mature genetic testing and embryo culture technology but the highest total cost; Thailand and Malaysia offer higher cost-effectiveness, but laboratory qualifications and embryologist experience need careful evaluation.

Most Overlooked Details

• Timing of AMH Test: Although AMH is not affected by the menstrual cycle, recent use of birth control pills or GnRH agonists can suppress AMH levels. It is recommended to test 2–3 months after stopping these medications.
• Fluctuation in Semen Analysis: Sperm quality is significantly affected by recent fever, sleep deprivation, or alcohol consumption. It is recommended to test at least twice, 2–4 weeks apart, and use the average for evaluation.
• Necessity of Genetic Counseling: Even if both partners have normal karyotypes, expanded carrier screening (carrier rate approx. 20–25%) is still recommended for older individuals or those with repeated failures to avoid risks of recessive genetic disorders.
• Medication Adherence After Transfer: Missing doses or prematurely stopping luteal phase support is a common cause of early miscarriage after transfer. Monitoring blood progesterone levels is especially important when using vaginal gel with unstable absorption.
• Jet Lag and Daily Routine: During跨国 treatment, disrupted day-night cycles can affect endocrine rhythms. It is advisable to arrive 2–3 days early to adjust to the time difference before starting the cycle.

Timeline Planning and Factors Affecting Cost

Timeline Reference:

• Preliminary Examinations and Documentation: 1–2 months (most tests completed domestically)
• Ovarian Stimulation to Egg Retrieval: 2–3 weeks (overseas stay)
• Embryo Culture + PGT (if needed): 2–4 weeks (can return home while waiting)
• Frozen Embryo Transfer: 1–2 weeks (overseas stay)
• Total: Approximately 3–6 months from preparation to transfer completion

Factors Affecting Cost: Medication dosage (lower AMH requires higher FSH doses), number of embryos undergoing PGT, use of third-party assistance, and need for multiple transfers. The cost for a complete cycle typically ranges from 80,000 to 350,000 RMB, with medication accounting for about 20–35% of the cost. PGT fees are calculated per embryo, approximately 3,000–6,000 RMB per embryo.

Real-Life Scenario Analysis

Scenario 1: 40 years old, AMH 0.7, two domestic failures

The core bottleneck for this group is egg quantity and quality. Overseas protocols often use PPOS or mild stimulation, aiming for multiple egg retrieval cycles to accumulate embryos before unified PGT testing. Clinical data show that for a 40-year-old woman, each retrieval cycle yields 0.3–0.6 euploid embryos. After accumulating 3–4 cycles, the live birth rate per transfer can reach 40–50%. Psychological and financial preparation is needed; a low number of eggs per cycle does not mean no chance, but expectations must be realistic.

Scenario 2: 35 years old, normal AMH, male DFI 28%

Male factors are easily overlooked. For couples with high DFI, the blastocyst formation rate may decrease by 15–20%. Management includes: lifestyle adjustments for the male (quit smoking, reduce sedentary time, supplement zinc and selenium), starting intervention 3–4 months before egg retrieval. Laboratories can use Zeta sperm selection or IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) to optimize sperm. Some centers recommend PGT-A to screen for euploid embryos.

Risk Reminder

This content is compiled based on overseas assisted reproduction coordination work and industry general data and does not constitute medical advice. Specific treatment plans should be based on evaluation by a fertility center physician. This knowledge base will be continuously updated to help those in need make rational decisions.